Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study

European Journal of Cancer

Volumn 48, Issue 6, 2012, Pages 875-881

  Sharma, Atul ^a   Rath, G K ^a   Chaudhary, S P ^a   Thakar, Alok ^b   Mohanti, Bidhu Kalyan ^a   Bahadur, Sudhir ^b  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemo radiotherapy; Lactobacillus CD2; Lozenges; Oral mucositis; Squamous cell carcinoma of head and neck

Indexed keywords

CISPLATIN; LACTOBACILLUS BREVIS CD2; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GRADING; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSGEUSIA; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LACTOBACILLUS BREVIS; LOZENGE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; ORAL MUCOSITIS; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VOMITING; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; INDIA; LACTOBACILLUS BREVIS; MALE; MIDDLE AGED; MOUTH MUCOSA; STOMATITIS; SURVIVAL ANALYSIS;

EID: 84859053993     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.06.010     Document Type: Article

References (22)

1. M.U.R. Naidu, G.V. Ramana, and P.U. Rani Chemotherapy-induced and/or radiation therapy-induced oral mucositis complicating the treatment of cancer Neoplasia 6 2004 423 431 (Pubitemid 39411078)
2. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804 (Pubitemid 28277960)
3. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086 (Pubitemid 30019568)
4. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098 (Pubitemid 37464533)
5. A.T. Chan, S.F. Leung, and R.K. Ngan Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Nat Cancer Inst 97 2005 536 539 (Pubitemid 40590436)
6. Sharma Atul, Mohanti Bidhu Kalyan, Thakar Alok, Bahadur Sudhir, Bhaskar Suman, Amit Bahl. Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial. Ann Oncol 2010; < doi:10.1093/annonc/mdq219 >.
7. D.M. Keefe, M.M. Schubert, and L.S. Elting Updated clinical practice guidelines for the prevention and treatment of mucositis Cancer 109 2007 820 831 (Pubitemid 46335677)
8. P. Delia, G. Sansotta, and V. Donato Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation Am J Gastroenterol 97 8 2002 2150 2152
9. L. Di Marzio, F.P. Russo, and S. D'Al Apoptotic effects of selected strains of lactic acid bacteria on a human T leucemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities Nutr Cancer 40 2001 185 196 (Pubitemid 34274926)
10. D.N. Riccia, F. Bizzini, and M.G. Perilli Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease Oral Dis 13 4 2007 376 385 (Pubitemid 46934569)
11. Rui-Dong Duan. Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids 2006;1761:281-91.
12. L.M. McManus, K.K. Ostrom, and C. Lear Radiation-induced increased platelet-activating factor activity in mixed saliva Lab Invest 68 1993 118 124 (Pubitemid 23055020)
13. Tasli ML, Mat C, De Simone C, et al. Lactobacillus lozenges in the management of oral ulcers of Behcet's syndrome. Clin Exp Rheumatol 2006; 24(5 Suppl 42):83-6.
14. Marshall RT. Microbiological count methods. In: Standard methods for the examination of dairy products. 16th ed. American Public Health Association; 1992 [chapter 6]. p. 213-6.
15. https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/Common-Toxicity- Criteria-CTC-v2.htm.
16. M. Vera-Llonch, G. Oster, and M. Hagiwara Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma: risk factors and clinical consequences Cancer 106 2006 329 336 (Pubitemid 43100441)
17. S.T. Sonis Pathobiology of oral mucositis: novel insights and opportunities J Support Oncol 5 2007 3 11 (Pubitemid 350031828)
18. R. Spielberger, P. Stiff, and W. Bensinger Palifermin for oral mucositis after intensive therapy for hematologic cancers New Engl J Med 351 2004 2590 2598 (Pubitemid 39628580)
19. D.M. Brizel, B.A. Murphy, I. David, and D.I. Rosenthal Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma J Clin Oncol 26 2008 2489 2496
20. H.G. Wu, S.Y. Song, and Y.S. Kim Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double- blind placebo-controlled prospective phase 2 multi-institutional clinical trial Cancer 115 2009 3699 3708
21. J.K. Ryu, S. Swann, and F. LeVeque The impact of concurrent granulocyte macrophage- colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901 Int J Radiat Oncol Biol Phys 67 2007 643 650 (Pubitemid 46215878)
22. M.J. van vilet, H.J. Harmsen, and E.S. de Bont The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis PLos Pathog 6 5 2010 e1000879